Abeona Therapeutics Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,042.00
925.00
1,040.00
889.00
837.00
2,998
Cost of Goods Sold (COGS) incl. D&A
128.00
11.00
-
-
-
-
Gross Income
1,914.00
914.00
-
-
-
-
SG&A Expense
5,718.00
4,045.00
18,660.00
23,945.00
27,932.00
58,804
EBIT
3,804.00
3,131.00
18,171.00
23,881.00
27,836.00
58,166
Unusual Expense
8,281.00
23,110.00
3,561.00
1,391.00
-
-
Non Operating Income/Expense
-
-
45.00
6.00
8.00
11
Interest Expense
279.00
582.00
6.00
-
-
-
Pretax Income
4,449.00
26,778.00
14,526.00
21,873.00
27,319.00
56,671
Consolidated Net Income
4,449.00
26,778.00
14,526.00
21,873.00
27,319.00
56,671
Net Income
4,449.00
26,778.00
14,526.00
21,873.00
27,319.00
56,671
Net Income After Extraordinaries
4,449.00
26,778.00
14,526.00
21,873.00
27,319.00
56,671
Net Income Available to Common
1,551.00
29,653.00
14,526.00
21,873.00
27,319.00
56,671
EPS (Basic)
3.00
15.26
0.53
0.64
0.66
1.19
Basic Shares Outstanding
504.90
1,942.90
27,597.40
34,180.30
41,636.80
47,528.20
EPS (Diluted)
3.04
15.26
0.53
0.64
0.66
1.19
Diluted Shares Outstanding
509.50
1,942.90
27,597.40
34,180.30
41,636.80
47,528.20
EBITDA
3,801.00
3,120.00
17,620.00
23,056.00
27,095.00
55,806
Non-Operating Interest Income
251.00
45.00
45.00
623.00
525.00
1,506
Preferred Dividends
2,898.00
2,875.00
-
-
-
-
About Abeona Therapeutics
View Profile
